Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Direct Meds vs NextMeds

An in-depth comparison of two leading GLP-1 Providers

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Direct Meds logo

Direct Meds

6.5
★★★☆☆3.3/5

Best for: compounded semaglutide at $249/month

Visit Direct Meds
VS
NextMeds logo

NextMeds

9.2
★★★★4.6/5

Best for: semaglutide at $79/month, 59% under the register median

Visit NextMeds

Two GLP-1 Providers chasing the same patients, trading off price, geography and what lands in the box differently. On our scoring, NextMeds opens cheaper — $79/mo against $249, and Direct Meds is where most people should begin. What follows: the prices, what each plan actually covers, the six-dimension score, where each one is weak, and who should pick which.

Pricing

Direct Meds

SublingualCompounded
$249/mo
semaglutide

Portal shows 'As low as $249.00'; inline JSON minMonthly $237 at some dosages; 90-day supply flow (SEMAGLUTIDE_SUB_90_MONTHLY). Unchanged vs our data.

InjectionCompounded
$297/mo
semaglutide

'As low as $297.00 or $9.58 per day'; flow code INT_MTH_084D_3PK (84-day 3-pack billed monthly). Unchanged vs our data.

SublingualCompounded
$299/mo
tirzepatide

CHANGED: was $399 in providers.json, now 'As low as $299.00 or $9.65 per day' (TIRZEPATIDE_SUB_90_MONTHLY_3MG_DAY).

InjectionCompounded
$399/mo
tirzepatide

'As low as $399.00 or $12.87 per day'; the '$9.58 per day' string on the public /products/tirzepatide marketing page is a copy error (matches sema math). Unchanged vs our data.

NextMeds

InjectableCompounded
$79/mo
semaglutide

Compounded Semaglutide Membership, drug included when prescribed, alongside telehealth visits, a care coach, a dietitian and shipping. $79 is the month-to-month rate read from the pricing section on 2026-08-14. The site headline reads 'from $49/mo': that is the 12-month prepaid term divided down, not a monthly price, and the ladder between them is 3-month $76, 6-month $73, 12-month $49. A summer promotion was running with a stated end of August 20, so $79 may itself be discounted.

InjectableCompounded
$109/mo
tirzepatide

Compounded Tirzepatide Membership, drug included when prescribed, alongside telehealth visits, a care coach, a dietitian and shipping. $109 is the month-to-month rate read from the pricing section on 2026-08-14. The advertised 'GLP-1 + GIP: $95' is the 12-month prepaid term divided down; the ladder is 3-month $105, 6-month $100, 12-month $95. A summer promotion was running with a stated end of August 20, so $109 may itself be discounted.

What’s included

Direct Meds

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

NextMeds

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

In the price

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

Direct Meds

6.5/10

Overall

NextMeds

9.2/10

Value25%

4.2A
vs
B
10.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

3.5A
vs
B
7.5

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
8.5

Features & Coverage

FeatureDirect MedsNextMeds
Starting Price$249/mo$79/mo
Features5 features8 features
States AvailableNot disclosed50
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted✓ Yes
FDA Warnings1 warningNone

About Direct Meds

The FDA sent Direct Meds a warning letter in September 2025 over misleading marketing, and customers have reported a documented pattern of unexpected 3-month commitment charges. We list the company with both disclosed in full; read the warnings and the cons first. Its products are compounded semaglutide and tirzepatide, sold from Utah in injection and sublingual form.

Read our full Direct Meds review →

About NextMeds

Membership is a single flat monthly charge, and inside it sit free shipping, a registered dietitian holding a license, a care coach working 1:1, telehealth visits and the drug itself where one is prescribed. Insurance is not billed. A free assessment online goes to a licensed provider, who adds a phone or video consult in states that demand one, then prescribes if it fits. Compounding pharmacies within the Next Meds network, all licensed, ship. Auto-renewal does not exist, cancellation is open, and all 50 states can order compounded tirzepatide and semaglutide.

Read our full NextMeds review →

Pros & Cons

Direct Meds

What we like

  • Semaglutide at $249 a month, within the normal band around this register's $189 median for the same drug and form
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly figure covers medication, consult, shipping

Watch-outs

  • No state list is on record here, so whether it serves your state cannot be confirmed from this page
  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
  • 1 FDA warning letter matched to this operator in our enforcement register — read what the letter alleges, since a letter discloses a problem rather than disqualifying a seller
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

NextMeds

What we like

  • Semaglutide at $79 a month, 58% below the $189 median for the same drug and form across this register
  • Tirzepatide at $109 a month, 59% below the $267 median for the same drug and form across this register
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
  • The monthly figure covers medication, consult, shipping, coaching
  • Coverage is published for all 50 states
  • No FDA warning letter matched this operator when we searched our enforcement register

Watch-outs

  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Direct Meds

Direct Meds is the one we would pick, particularly on compounded semaglutide at $249/month. NextMeds is a real alternative if semaglutide at $79/month, 59% under the register median is what you are after — the six-dimension breakdown and the prices below are what to weigh against your own case.

Choose Direct Meds if…

You want compounded semaglutide at $249/month and an opening price near $249 a month.

Choose NextMeds if…

You want semaglutide at $79/month, 59% under the register median and an opening price near $79 a month.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.9

Oak

Semaglutide at $119/month, 37% under the register median

6.5

Direct Meds

Compounded semaglutide at $249/month

7.7

Try Ageless

Semaglutide at $119/month, 37% under the register median

Direct Meds vs NextMeds: FAQ

Glossary

The words sellers use, defined. Tap any term.

Continue exploring Direct Meds and NextMeds head-to-heads in the same category.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.